Literature DB >> 17322994

Comparison between endoscopic papillary balloon dilatation and endoscopic sphincterotomy for the treatment of common bile duct stones.

Hidetaka Watanabe1, Masashi Yoneda, Keiichi Tominaga, Tsuneo Monma, Kazunari Kanke, Tadahito Shimada, Akira Terano, Hideyuki Hiraishi.   

Abstract

BACKGROUND: This study was designed to evaluate the therapeutic outcome and early postoperative complications, especially pancreatitis, of endoscopic papillary balloon dilation (EPBD) and endoscopic sphincterotomy (EST) in patients with common bile duct stones in our department.
METHODS: One hundred eighty patients with common bile duct stones were randomized to undergo EPBD or EST. An 8-mm dilatation balloon was used for EPBD. Modified Cotton's criteria, in which relatively mild pancreatitis is also included as a complication, were used to determine the incidence of postoperative complications.
RESULTS: The rate of complete removal of stones was significantly higher in the EST group (95.6%) than in the EPBD group (86.6%); for stones less than 10 mm in diameter, however, the rate with EPBD (93.8%) was almost equivalent to that with EST (98.1%). According to modified Cotton's criteria, the incidence of postoperative pancreatitis was significantly higher in the EPBD group (16.7%) than in the EST group (6.7%). Bleeding was encountered in one patient (1.1%) in the EST group, but in none in the EPBD group. No fatal complication occurred in either the EPBD or the EST group.
CONCLUSIONS: Although EPBD appears to be comparable to EST for removal of small common bile duct stones, mild postoperative pancreatitis is more likely to occur with EPBD than with EST.

Entities:  

Mesh:

Year:  2007        PMID: 17322994     DOI: 10.1007/s00535-006-1969-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  30 in total

1.  Endoscopic papillary balloon dilation and endoscopic sphincterotomy for bile duct stones: long-term outcomes in a prospective randomized controlled trial.

Authors:  Shouichi Tanaka; Tomoyuki Sawayama; Toshifumi Yoshioka
Journal:  Gastrointest Endosc       Date:  2004-05       Impact factor: 9.427

2.  Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones.

Authors:  James A Disario; Martin L Freeman; David J Bjorkman; Padraic Macmathuna; Bret T Petersen; Philip E Jaffe; Thomas G Morales; Lee J Hixson; Stuart Sherman; Glen A Lehman; M Mazen Jamal; Firas H Al-Kawas; Mukul Khandelwal; Joseph P Moore; Gregory A Derfus; Priya A Jamidar; Francisco C Ramirez; Michael E Ryan; Karen L Woods; David L Carr-Locke; Stephen C Alder
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

3.  Endoscopic sphincterotomy in 1000 consecutive patients.

Authors:  D Vaira; L D'Anna; C Ainley; J Dowsett; S Williams; J Baillie; S Cairns; J Croker; P Salmon; P Cotton
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

4.  [Endoscopic sphincterotomy of the papilla of vater and extraction of stones from the choledochal duct (author's transl)].

Authors:  M Classen; L Demling
Journal:  Dtsch Med Wochenschr       Date:  1974-03-15       Impact factor: 0.628

5.  Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones. A randomized trial with manometric function.

Authors:  A Minami; T Nakatsu; N Uchida; S Hirabayashi; H Fukuma; S A Morshed; M Nishioka
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

6.  Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.

Authors:  G Cavallini; A Tittobello; L Frulloni; E Masci; A Mariana; V Di Francesco
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

7.  Predictive factors for acute pancreatitis and hyperamylasemia after endoscopic papillary balloon dilation.

Authors:  Masanori Sugiyama; Yumi Izumisato; Nobutsugu Abe; Tadahiko Masaki; Toshiyuki Mori; Yutaka Atomi
Journal:  Gastrointest Endosc       Date:  2003-04       Impact factor: 9.427

8.  Endoscopic sphincteroplasty: a novel and safe alternative to papillotomy in the management of bile duct stones.

Authors:  P Mac Mathuna; P White; E Clarke; J Lennon; J Crowe
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Treatment of choledocholithiasis in patients with liver cirrhosis. Surgical treatment or endoscopic sphincterotomy?

Authors:  M Sugiyama; Y Atomi; A Kuroda; T Muto
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

10.  Endoscopic sphincterotomy vs. endoscopic papillary balloon dilation for choledocholithiasis in patients with liver cirrhosis and coagulopathy.

Authors:  Do Hyun Park; Myung-Hwan Kim; Sung Koo Lee; Sang Soo Lee; Jung Sik Choi; Moon Hee Song; Dong Wan Seo; Young Il Min
Journal:  Gastrointest Endosc       Date:  2004-08       Impact factor: 9.427

View more
  20 in total

1.  Ampulla dilation with different sized balloons to remove common bile duct stones.

Authors:  Neng-Ping Li; Jiang-Qi Liu; Zhi-Qiang Zhou; Tao-Ying Ji; Xiao-Yan Cai; Qing-Yun Zhu
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 2.  Comparison of endoscopic papillary balloon dilatation and endoscopic sphincterotomy for bile duct stones.

Authors:  Yuji Sakai; Toshio Tsuyuguchi; Harutoshi Sugiyama; Masahiro Hayashi; Jun-Ichi Senoo; Yuko Kusakabe; Shin Yasui; Rintaro Mikata; Osamu Yokosuka
Journal:  World J Gastrointest Endosc       Date:  2016-05-25

Review 3.  Endoscopic Papillary Large Balloon Dilation Versus Endoscopic Sphincterotomy for Treatment of Bile Duct Stones.

Authors:  Abdul Haseeb; Martin L Freeman
Journal:  Curr Treat Options Gastroenterol       Date:  2019-06

4.  Factors associated with delayed hemorrhage after endoscopic sphincterotomy: Japanese large single-center experience.

Authors:  Satoshi Ikarashi; Akio Katanuma; Toshifumi Kin; Kuniyuki Takahashi; Kei Yane; Itsuki Sano; Hajime Yamazaki; Hiroyuki Maguchi
Journal:  J Gastroenterol       Date:  2017-05-06       Impact factor: 7.527

5.  The ballooning time in endoscopic papillary balloon dilation for the treatment of bile duct stones.

Authors:  Byoung Wook Bang; Seok Jeong; Don Haeng Lee; Jung Il Lee; Jin-Woo Lee; Kye Sook Kwon; Hyung Gil Kim; Yong Woon Shin; Young Soo Kim
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 2.884

6.  Successful endoscopic sphincterotomy for choledocholithiasis in a patient with severe hemophilia A and inhibitors.

Authors:  Ryo Sugiura; Masaki Kuwatani; Kazumichi Kawakubo; Itsuki Sano; Shin Kato; Tomoyuki Endo; Naoya Sakamoto
Journal:  Clin J Gastroenterol       Date:  2018-02-02

7.  Endoscopic papillary large balloon dilation for treatment of large bile duct stones does not increase the risk of post-procedure pancreatitis.

Authors:  Jun Suk Park; Tae Nyeun Kim; Kook Hyun Kim
Journal:  Dig Dis Sci       Date:  2014-07-05       Impact factor: 3.199

Review 8.  Is endoscopic papillary balloon dilatation really a risk factor for post-ERCP pancreatitis?

Authors:  Toshio Fujisawa; Koichi Kagawa; Kantaro Hisatomi; Kensuke Kubota; Atsushi Nakajima; Nobuyuki Matsuhashi
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

Review 9.  Endoscopic papillary balloon dilation: revival of the old technique.

Authors:  Seung Uk Jeong; Sung-Hoon Moon; Myung-Hwan Kim
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

Review 10.  Prevention of post-ERCP pancreatitis.

Authors:  Jennifer Maranki; Paul Yeaton
Journal:  Curr Gastroenterol Rep       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.